However, genome-wide association studies (GWAS) have linked FXR1 to schizophrenia and bipolar disorders (Consortium, 2014; Hauberg et al., 2016; Liu et al., 2016; Takata et al., 2017), therefore indicating its possible wider roles in mental illnesses. The gene discussed is FXR1; the disease is psychiatric disorder.